Table 3.
Results of susceptibility testing for Gram-positive isolates (N=28).
| Antimicrobials |
S.aureus (N=15), n (%) susceptible |
S.epidermidis (N=7), n (%) susceptible |
S.agalactiae (N=6), n (%) susceptible |
|---|---|---|---|
| Beta-lactam | |||
| Oxacillin | 9 (60) | 3 (43) | *** |
| Amoxicillin | 5 (33) | 1 (14) | *** |
| Amoxicillin clavulanate |
6 (40) | 3 (43) | *** |
| Piperacillin/ Tazobactam |
11 (73) | 3 (43) | *** |
| Cefotaxime | *** | *** | 5 (83) |
| Ceftriaxone | 13 (87) | 6 (86) | 5 (83) |
| Imipenem | 14 (93) | 7 (100) | 6 (100) |
| Meropenem | 14 (93) | 7 (100) | 6 (100) |
| Non-beta-lactam | |||
| Ciprofloxacin | 13 (87) | 4 (57) | 5 (83) |
| Moxifloxacin | 13 (87) | 4 (57) | 5 (83) |
| Clindamycin | 11 (73) | 2 (29) | 4 (67) |
| Erythromicin | 10 (67) | 2 (29) | 3 (50) |
| Tetracycline | 9 (60) | 5 (71) | 4 (67) |
| Rifampin | 11 (73) | 6 (86) | 5 (83) |
| SMX-TM | 13 (87) | 3 (43) | *** |
| Vancomycin | 15 (100) | 7 (100) | 5 (83) |
Note.
***
- not tested for susceptibility to this antibiotic/antimicrobial.
SMX-TM - Trimetoprim sulfametoxazol.